Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MODIFIED NUCLEOSIDE AND SYNTHESIS METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2021/027614
Kind Code:
A1
Abstract:
A modified cytidine compound, that is, an aminooxy group is modified at the 4-position of a cytidine pyrimidine ring to produce derivative cytidine and nucleic acid containing the derivative cytidine, such as RNA. The expression level of the nucleic acid containing the modified cytidine, in particular mRNA, in the body is significantly improved.

Inventors:
CAI YUNSONG (CN)
LI HANGWEN (CN)
LIU LIANXIAO (CN)
LI NING (CN)
Application Number:
PCT/CN2020/106696
Publication Date:
February 18, 2021
Filing Date:
August 04, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
STEMIRNA THERAPEUTICS CO LTD (CN)
International Classes:
A61K31/7068; C07H19/067; A61K31/7105; A61K31/711; A61P35/00; C07H1/00; C07H19/073; C07H19/10; C07H21/02; C07H21/04
Domestic Patent References:
WO2017156380A12017-09-14
WO2007024708A22007-03-01
Foreign References:
CN107427529A2017-12-01
CN102695525A2012-09-26
Other References:
KOCHETKOV, N.K. ET AL.: "Selective Modification of Uridine and Guanosine", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 87, no. 3, 31 December 1964 (1964-12-31), XP025828603, ISSN: 0926-6550, DOI: 20200909155350A
Attorney, Agent or Firm:
HANGZHOU TIANHAO PATENT AGENCY CO., LTD (CN)
Download PDF: